showed a trendp = 0.058
However, after PSM, carvedilol at doses >25 mg/day significantly reduced 30-day (HR = 0.50 95%CI: 0.30, 0.85, p = 0.011) and 360-day all-cause mortality (HR = 0.68 95%CI: 0.49, 0.94, p = 0.020) and showed a trend toward reducing 7-day all-cause mortality (HR = 0.46 95%CI: 0.20, 1.03, p = 0.058), though without statistical significance.